Clinical Outcomes of Low-Dose Methotrexate Therapy as a Second-Line Drug for Intravenous Immunoglobulin-Resistant Kawasaki Disease

PURPOSE: Intravenous immunoglobulin (IVIG) is the standard treatment for Kawasaki disease (KD). However, there is still no standard treatment for IVIG-resistant KD. This study aimed to evaluate the efficacy of low-dose methotrexate (MTX) as a treatment for IVIG-resistant KD. MATERIALS AND METHODS: W...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Yonsei Med J
Prif Awduron: Jang, Hyejin, Kim, Kyu Yeun, Kim, Dong Soo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Yonsei University College of Medicine 2018
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5725347/
https://ncbi.nlm.nih.gov/pubmed/29214785
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3349/ymj.2018.59.1.113
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg